Загрузка...
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
Abstract Background Sodium glucose co-transporter2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we investigated the effects of long-term treatment with canagliflozin on bioche...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2018-07-01
|
| Серии: | Cardiovascular Diabetology |
| Предметы: | |
| Online-ссылка: | http://link.springer.com/article/10.1186/s12933-018-0749-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|